Congratulations to Arul M. Chinnaiyan, MD, PhD, on his prestigious election to the National Academy of Science! Chinnaiyan is an investigator, Howard Hughes Medical Institute; and S.P. Hicks Endowed Professor of Pathology, American Cancer Society Research Professor, and director, Michigan Center for Translational Pathology, University of.
Arul M. Chinnaiyan, MD, PhD, Director, Michigan Center for Translational Pathology, and S.P. Hicks Endowed Professor of Pathology; was among the group of distinguished cancer scientists called to Washington DC to give advice on how research can help bring to reality Vice President Biden's hope for a.Arul M. Chinnaiyan is a Hicks Endowed Professor of Pathology and professor of pathology and urology at the University of Michigan Medical School. He is also a Howard Hughes medical Investigator (HHMI) at the Howard Hughes Medical Institute. Arul Chinnaiyan received both PhD and MD degrees at the University of Michigan Medical School in 1999.When Arul Chinnaiyan, MD, PhD, was pursuing his medical and doctoral degrees at the University of Michigan in Ann Arbor, he knew he wanted his research to have direct applications to clinical care. Growing up in Chicago and Ann Arbor, Dr. Chinnaiyan was drawn to science by an inspirational high school biology teacher.
Translating Cancer Genomes and Transcriptomes for Precision Oncology Sameek Roychowdhury, MD, PhD1,2,3; Arul M. Chinnaiyan, MD, PhD4,5,6,7,8,9 Understanding the molecular landscape of cancer has facilitated the development of diagnostic, prognostic, and predictive bio-.
Arul M. Chinnaiyan was born near Cleveland, Ohio, but spent his first years in a suburb of Chicago, Illinois, the elder of two sons whose parents came from India. His father was an electrical engineer, his mother a housewife. When Chinnaiyan was about thirteen the family moved to Ann Arbor, Michigan, where his father had taken a job.
Investigator: Arul M. Chinnaiyan, MD, PhD; University of Michigan Medical School My current grant is focused on therapeutic targeting of this molecule called SPINK-1. We discovered that about 10% of prostate cancer patients have elevated SPINK-1 levels which we find in more aggressive prostate cancers, and this is in a population of patients that don’t have these molecular aberrations called.
Arul Chinnaiyan, MD, PhD. Professor, Departments of Pathology and Urology at University of Michigan Medical School Clinical Pathology; Professor, Departments of Pathology and Urology at University of Michigan Medical School; Want to learn more about Arul? Join NEJM Resident 360! Create a free account Create Your Account. LinkedIn Facebook.
Arul Chinnaiyan, MD, PhD. University of Michigan Ann Arbor, Michigan. Class of 2020. 615 Chestnut St., 17th Floor Philadelphia, PA 19106-4404 USA Telephone: 215-440-9300 Email: (email protected) Our Sites. AACR Journals; myAACR; AACR Foundation; AACR Cancer Progress Report; Cancer Today Magazine.
New Approaches in Understanding and Treating Obesity S.P. Hicks Endowed Professor of Pathology Professor of Urology Director, U-M Center for Translational Pathology Howard Hughes Medical Institute Investigator Dr. Chinnaiyan is an expert in the clinical care of patients with cancers, particularly prostate cancer. In thelaboratory, he is using functional genomic, proteomic, and bioinformatics.
CA: A Cancer Journal for Clinicians publishes information about the prevention, early detection, and treatment of cancer, as well as nutrition, palliative care, survivorship, and additional topics of interest related to cancer care.
Dr. Chinnaiyan also formed Armune Bioscience to develop and commercialize new diagnostic tests for prostate, lung and breast cancers. And in 2012 he joined with Shaumeng Wang, professor of medicine, pharmacology and medicinal chemistry, to found OncoFusion Therapeutics, a company that aims to develop personalized cancer therapies based on the specific driving genetic mutations in an individual.
Arul Moli Chinnaiyan MD PhD Pathology. Ann Arbor, MI. Molecular Genetics,. Dr. Chinnaiyan is on Doximity As a Doximity member you'll join over a million verified healthcare professionals in a private, secure network. Connect with other colleagues in the same hospital or clinic.
The Critical Role of the Pathologist in Determining Eligibility for Active Surveillance as a Management Option in Patients With Prostate Cancer. (Mark Rubin, MD (team lead); Arul Chinnaiyan, MD, PhD; Lawrence True, MD; and Beatrice Knudsen, MD, PhD).
View Arul Chinnaiyan’s profile on LinkedIn, the world's largest professional community. Arul has 2 jobs listed on their profile. See the complete profile on LinkedIn and discover Arul’s.
Arul Chinnaiyan, MD, PhD. Professor, Departments of Pathology and Urology at University of Michigan Medical School. Want to learn more about Arul? Join Medstro! Medstro is a new collaborative physician and medical student community for connecting, finding mentors, and finding new traditional and non-traditional jobs and research opportunities.
Arul Chinnaiyan, MD, PhD. Professor of Pathology, Urology. Director, Michigan Center for Translational Pathology. University of Michigan Medical School. . Senior Associate Dean for Faculty and Faculty Development. Professor, Department of Internal Medicine. University of Michigan Medical School.
Arul M. Chinnaiyan, MD, PhD Ajjai Alva, MD. With the wide-spread integration of next-generation sequencing technology over the past several years, comprehensive genomic studies have shown that prostate cancers can be classified into different molecular subtypes.